Home/Hedge Fund Intelligence/Indivior Pharmaceuticals Inc
INDVStockForm 13F30 Jun 2026

Hedge funds that hold Indivior Pharmaceuticals Inc INDV

CUSIP 45579U109 · who reports it, how much, and how much it matters to them

27 of the 720 hedge fund managers we track reported shares of Indivior Pharmaceuticals Inc (INDV) on Form 13F for 30 June 2026. Between them they reported USD 893m. The largest position belongs to Oaktree Capital Management, at USD 251m. The manager with the most riding on it is Mangrove Partners Im, where it is 7.2% of the reported book.

Managers reporting it27of 720 we track
Value they reportUSD 893mshares only, 30 Jun 2026
Funds they run648with a file on PPLI.com
Largest positionUSD 251mOaktree Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight7.2%Mangrove Partners Im

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

27 managers, USD 893m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Indivior Pharmaceuticals Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Oaktree Capital Management219 funds on PPLI.comUSD 251m3.5%
2Madison Avenue Partners1 fund on PPLI.comUSD 118m5.1%
3Mangrove Partners Im1 fund on PPLI.comUSD 110m7.2%
4Citadel Advisors32 funds on PPLI.comUSD 109m0.0%
5Millennium Management6 funds on PPLI.comUSD 86m0.0%
6Newtyn Management3 funds on PPLI.comUSD 54m6.7%
7POINT72 Asset Management17 funds on PPLI.comUSD 51m0.1%
8Melqart Asset Management (UK)3 funds on PPLI.comUSD 24m2.3%
9Alta Fundamental Advisers21 funds on PPLI.comUSD 17m5.0%
10PFM Health Sciences3 funds on PPLI.comUSD 16m1.4%
11Two Sigma Investments35 funds on PPLI.comUSD 13m0.0%
12Rock Springs Capital Management2 funds on PPLI.comUSD 10m0.5%
13D. E. Shaw & Co.15 funds on PPLI.comUSD 9.7m0.0%
14Schonfeld Strategic Advisors30 funds on PPLI.comUSD 5.4m0.0%
15Aquatic Capital Management3 funds on PPLI.comUSD 5m0.2%
16Campbell & Company Investment Adviser8 funds on PPLI.comUSD 2.9m0.1%
17Bridgewater Associates45 funds on PPLI.comUSD 2.8m0.0%
18Exoduspoint Capital Management7 funds on PPLI.comUSD 2.1m0.0%
19Capital Fund Management S.A.12 funds on PPLI.comUSD 1.5m0.0%
20Balyasny Asset Management25 funds on PPLI.comUSD 1.2m0.0%
21Persistent Asset Partners10 funds on PPLI.comUSD 1m0.3%
22Brevan Howard Capital Management39 funds on PPLI.comUSD 497,0000.0%
23Squarepoint Ops7 funds on PPLI.comUSD 413,0000.0%
24Oxford Asset Management LLP2 funds on PPLI.comUSD 356,0000.2%
25Magnetar Financial93 funds on PPLI.comUSD 322,0000.0%
26Fulcrum Asset Management LLP7 funds on PPLI.comUSD 8,2520.0%
27Elequin Capital2 funds on PPLI.comUSD 4100.0%
Next: where it matters most
Where it matters most

For Mangrove Partners Im it is 7.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Mangrove Partners ImUSD 110m7.2%
2Newtyn ManagementUSD 54m6.7%
3Madison Avenue PartnersUSD 118m5.1%
4Alta Fundamental AdvisersUSD 17m5.0%
5Oaktree Capital ManagementUSD 251m3.5%
6Melqart Asset Management (UK)USD 24m2.3%
7PFM Health SciencesUSD 16m1.4%
8Rock Springs Capital ManagementUSD 10m0.5%
9Persistent Asset PartnersUSD 1m0.3%
10Oxford Asset Management LLPUSD 356,0000.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Indivior Pharmaceuticals Inc

What is the ticker symbol of Indivior Pharmaceuticals Inc?

Indivior Pharmaceuticals Inc trades under the symbol INDV. Its CUSIP, the code used on Form 13F, is 45579U109.

Which hedge funds own Indivior Pharmaceuticals Inc (INDV)?

27 of the 720 hedge fund managers PPLI.com tracks reported Indivior Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Oaktree Capital Management (USD 251m), Madison Avenue Partners (USD 118m), Mangrove Partners Im (USD 110m), Citadel Advisors (USD 109m) and Millennium Management (USD 86m).

How many hedge funds hold Indivior Pharmaceuticals Inc?

27 managers in our coverage reported it, and between them they run 648 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Indivior Pharmaceuticals Inc?

Mangrove Partners Im, where the position was 7.2% of the reported 13F book at 30 June 2026.

Does this show who is short Indivior Pharmaceuticals Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Indivior Pharmaceuticals Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.